Transaction DateRecipientSharesTypePriceValue
1st December 2020Ahmed Zaki Sabet222Open or private purchase$2.23$495.06
1st December 2020Ilan Danieli1,111Open or private purchase$2.23$2,477.53
1st September 2020Ahmed Zaki Sabet130Open or private purchase$2.16$281.23
1st September 2020Ilan Danieli1,150Open or private purchase$2.15$2,466.75
7th July 2020Ahmed Zaki Sabet169Open or private purchase$1.60$270.40
7th July 2020Ahmed Zaki Sabet281Open or private purchase$0.96$269.76
6th July 2020Ilan Danieli1,550Open or private purchase$1.60$2,480.00
6th July 2020Ilan Danieli2,585Open or private purchase$0.96$2,481.60
2nd December 2019Ahmed Zaki Sabet127Open or private purchase$2.11$267.55
2nd December 2019Ilan Danieli1,176Open or private purchase$2.09$2,463.13
Precipio logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

Precipio, Inc. was founded in March 1997 and is headquartered in New Haven, CT. Its products and services include MX-ICP and HemeScreen HRM kits, SmartPath, SmartGen and ICP liquid biopsy testing.

Ticker: PRPO
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1043961
Employees: 51
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags